共 77 条
[1]
Mandelblatt JS(2013)Costs, evidence, and value in the Medicare program: the challenges of technology innovation in breast cancer prevention and control JAMA Intern Med 173 227-228
[2]
Tosteson AN(2014)Breast cancer statistics, 2013 CA Cancer J Clin 64 52-62
[3]
van Ravesteyn NT(2006)Estrogen carcinogenesis in breast cancer N Engl J Med 354 270-282
[4]
DeSantis C(2014)Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer J Natl Cancer Inst 106 1-6
[5]
Yager JD(2012)Tamoxifen versus raloxifene versus exemestane for chemoprevention Curr Breast Cancer Rep 4 207-215
[6]
Davidson NE(1998)Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J Natl Cancer Inst 90 1371-1388
[7]
Garcia-Closas M(2005)Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study J Natl Cancer Inst 97 1652-1662
[8]
Gunsoy NB(2003)Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women J Natl Cancer Inst 95 160-165
[9]
Chatterjee N(2007)Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy J Natl Cancer Inst 99 727-737
[10]
Reimers L(1998)Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial Lancet 352 98-101